… vulnerable to dysregulation of A-to-I RNA editing. Here, we focus on how aberrant A-to-I
RNA editing is involved in neurological and neurodegenerative diseases of humans including …

… A-to-I RNA editing process and its contribution to neurodegenerative diseases. Schematic
representation showing A-to-I RNA editing process and its implications in Amyotrophic lateral …

… or regulations, potentially involving in neurodegenerative pathogenesis. Its variabilities are
… of neurodegenerative disease-susceptibility variants from the view of A-to-I RNA editing, we …

… events were reported in different organisms, and corresponding databases (RADAR,
rigorously annotated database of A-to-I RNA editing [67], DARNED [68], and REDIportal [69] have …

… , in neurodegenerative diseases. These ncRNA species are ripe for research to analyze
whether RNA editing … Furthermore, the fact that binding of ADARs in the absence of editing also …

… us understand neurodegenerative pathogenesis. In this study, we identified 9897 A-to-I RNA
editing … in the pathogenesis of neurological and neurodegenerative disorders. For example, …

… proteins in axons of motor neurons is observed, but as for other types of protein deposits
associated with several neurodegenerative diseases (such as Alzheimer’s and Parkinson …

… the failure of A-to-I RNA editing in neurological diseases. Moreover, as … of RNA editing with
neurodegenerative diseases or current and promising gene therapies for neurodegeneration …

… of differences in A-to-I RNA editing levels and specificity of mRNA editing sites in brain …
reported evaluations of RNA editing levels in other neurodegenerative diseases. Increased …

… RNA editing deficits for chronic and acute neurodegenerative disorders, neuropsychiatric
diseases… miRNAs can undergo A-to-I RNA editing at premature states when the miRNA has a …